CD10 Expression As a Potential Predictor of Pathological Complete Response in ER-negative and Triple-Negative Breast Cancer Patients Treated with Anthracycline-Based Neoadjuvant Chemotherapy.
EXPERIMENTAL AND MOLECULAR PATHOLOGY（2024）
Key words
Breast cancer,Neoadjuvant chemotherapy,Pathological complete response,CD10,Predictive marker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined